Inspire Medical Systems (NYSE:INSP), known for its innovative devices that use neurostimulation to treat sleep apnea, ...

Inspire Medical Systems (INSP) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.49 per share a year ago.

Inspire Medical Systems said it is cooperating with U.S. Justice Department probe of allegations into allegations of false claims related to its Inspire system apnea implant. Shares fall 5.5% to $171 ...

These studies have revealed that strategically timed naps can be as restorative as long periods of sleep, leading to the creation of advanced devices that enhance the benefits of napping through ...

NEW YORK – For many adults in the United States, sleep deprivation is a problem that can affect both physical and mental health. Research suggests that chronic poor sleep raises your risk of ...

device at night or receiving no treatment. In the analysis of data on 2,832,437 patients with obstructive sleep apnea, 3.4% of patients who underwent surgery were in a car accident at any point ...

Pune, Jan. 21, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Sleep Apnea Devices Market size was valued at USD 5.25 billion in 2023 and is expected to reach USD 9.43 billion by 2032 ...

Leadership is about impact. As Adam Galinsky emphasizes in his new book INSPIRE: The Universal Path for Leading Yourself and Others, leaders don’t have the luxury of neutrality. “Neutrality is ...

Medicare covers sleep tests for certain conditions such as sleep apnea, narcolepsy, or parasomnia, but limitations may apply.

(MENAFN- GlobeNewsWire - Nasdaq) Rising prevalence of sleep apnea, technological advancements in treatment devices, and increasing public awareness drive robust growth in the sleep apnea devices ...

Medicare covers sleep ... devices that you take home to perform the test yourself while you sleep in your own bed. Medicare Part B covers any of these sleep studies to screen for obstructive sleep ...